Core Viewpoint - The company Xiangrikui (stock code: 300111) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged misleading statements in its restructuring proposal, which has raised market concerns regarding the actual production capacity and business model of the restructuring target [2][4]. Group 1: Legal Proceedings - On February 10, 2026, the Shaoxing Intermediate People's Court accepted a compensation case filed by investors against Xiangrikui, represented by attorney Xu Feng from Shanghai Jiucheng Law Firm [1][3]. - The law firm is actively pursuing additional cases and accepting more investor claims for compensation related to the alleged violations [1][3]. Group 2: Regulatory Actions - On January 14, 2026, the CSRC issued a notice indicating that the Zhejiang Securities Regulatory Bureau has initiated an investigation into Xiangrikui's restructuring proposal due to suspected misleading statements [2][4]. - The investigation was prompted by market doubts regarding the actual production capacity and business model of the restructuring target, leading to a formal inquiry by the regulatory authority [2][4]. Group 3: Investor Claims - Investors who purchased Xiangrikui shares between September 22, 2025, and December 26, 2025, and sold or continued to hold the shares after December 26, 2025, are eligible to file for compensation based on the violations identified [3][5].
向日葵(300111)投资者索赔案获得法院立案